Literature DB >> 7868920

In vitro production of monoclonal antibodies in high concentration in a new and easy to handle modular minifermenter.

F W Falkenberg1, H Weichert, M Krane, I Bartels, M Palme, H O Nagels, H Fiebig.   

Abstract

This paper describes a new and easy to handle reusable minifermenter for high-density culture of hybridoma and other cells. The culture apparatus is composed of two modules: a 40 ml disposable cell culture and antibody production chamber (the 'production module') and a 550 ml medium reservoir (the 'supply module'). The two modules are separated from each other by a dialysis membrane allowing passage of low molecular mass nutrients and metabolites. The monoclonal antibodies are produced and enriched in the production module. The outer part of this module is made from a thin gas-permeable silicone rubber membrane allowing exchange of gases (oxygen and carbon dioxide). To start the culture, the cells are injected into the production module through ports in the silicone rubber which are equipped with Luer Lock connectors. Samples can be removed in the same way. For culturing, the minifermenter is rolled on a roller apparatus in a carbon dioxide-supplied incubator. Depending on the individual properties of the hybridoma cells cultured, cell densities of more than 10 x 10(6) (in some cases up to 35 x 10(6)) cells per ml and monoclonal antibody concentrations of several mg per ml can be obtained in the new minifermenter. On average, 61 mg (range: 9-159 mg) could be produced within 1-4 weeks. In terms of their properties the monoclonal antibodies produced in the new modular minifermenter were indistinguishable from antibodies prepared from ascitic fluid or from the supernatant of conventional stationary culture. The culture method is a useful alternative to the in vivo production method in mice. In addition, it represents a completely new, inexpensive and easy to handle general solution to the problem of culturing cells in high density and obtaining cellular products in high concentrations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7868920     DOI: 10.1016/0022-1759(94)00266-y

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

1.  Scale-up of suspension and anchorage-dependent animal cells.

Authors:  B Griffiths
Journal:  Mol Biotechnol       Date:  2001-03       Impact factor: 2.695

2.  Development of optimal medium for production of commercially important monoclonal antibody 520C9 by hybridoma cell.

Authors:  Sucharita Sen; Pradip K Roychoudhury
Journal:  Cytotechnology       Date:  2012-07-19       Impact factor: 2.058

3.  Distribution of heme oxygenase isoforms in rat liver. Topographic basis for carbon monoxide-mediated microvascular relaxation.

Authors:  N Goda; K Suzuki; M Naito; S Takeoka; E Tsuchida; Y Ishimura; T Tamatani; M Suematsu
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

4.  Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice.

Authors:  K G Tournoy; S Depraetere; R A Pauwels; G G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

5.  The 180 splice variant of NCAM-containing exon 18-is specifically expressed in small cell lung cancer cells.

Authors:  Ann Vander Borght; Mieke Duysinx; Jos L V Broers; Monique Ummelen; Frank W Falkenberg; Christine Hahnel; Bernard A M van der Zeijst
Journal:  Transl Lung Cancer Res       Date:  2018-06

6.  Three-Dimensional Culture of Hybridoma Cells Secreting Anti-Human Chorionic Gonadotropin by a New Rolling Culture System.

Authors:  Yan Wang; Hong-Li Jiao; Jin-Zhu Zhang; Rong-Qiao He
Journal:  J Biomed Biotechnol       Date:  2004
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.